# New blood cancer therapy successful in three-quarters of trial patients

- Link: https://www.widthness.com/new-blood-cancer-therapy-successful-in-three-quarters-of-trial-patients/
- Published: 2022-12-13T09:00:32-06:00
- Author: Curated by Theresa Wysocki

Image caption: The new treatment is currently under application for review by the FDA. Depositphotos. Article by Rich Haridy. New Atlas – December 11, 2022. New data from an ongoing Phase 1/2 clinical trial has revealed an experimental immunotherapy led to successful response rates in 73% of patients suffering from multiple myeloma, a deadly form of blood cancer. Based on this promising data, an application to the US Food and Drug Administration (FDA) has been filed to bring the drug to market. […] Click here to view original web page at newatlas.com Curated by Theresa Wysocki Director of Art & Design See Full Bio